Vitrolife Update: Modest stable growth with great margins - Redeye

Vitrolife delivered a consecutive positive organic growth recovery with 6% organic growth in constant currencies (CER). The last three quarters are near market growth. The extra 4-5% growth needed to reach its target of >10% will take longer, considering that some 3% of Vitrolife’s business will fade out to comply with sanctions and international policies during 2025.

Länk till analysen i sin helhet: https://www.redeye.se/research/1071218/vitrolife-update-modest-stable-growth-with-great-margins?utm_source=finwire&utm_medium=RSS